{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:43:27Z","timestamp":1782823407621,"version":"3.54.5"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11033-022-07224-4","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T21:03:02Z","timestamp":1649883782000},"page":"5133-5152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Potential diagnostic and prognostic of efferocytosis-related unwanted soluble receptors\/ligands as new non-invasive biomarkers in disorders: a review"],"prefix":"10.1007","volume":"49","author":[{"given":"Amir","family":"Tajbakhsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Gheibihayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramezan Ali","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fasihi-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl Nesaei","family":"Bajestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1960-7251","authenticated-orcid":false,"given":"Abolfazl","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"7224_CR1","first-page":"2019","volume":"20","author":"AC Doran","year":"2019","unstructured":"Doran AC, Yurdagul A, Tabas I (2019) Efferocytosis in health and disease. Nat Rev Immunol 20:2019","journal-title":"Nat Rev Immunol"},{"key":"7224_CR2","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1371\/journal.pone.0076039","volume":"8","author":"B Nativel","year":"2013","unstructured":"Nativel B, Marimoutou M, Thon-Hon VG, Gunasekaran MK, Andries J, Stanislas G, Planesse C, Da Silva CR, Cesari M, Iwema T, Gasque P, Viranaicken W (2013) Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. PLoS ONE 8:2013","journal-title":"PLoS ONE"},{"key":"7224_CR3","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1007\/s11033-021-06547-y","volume":"48","author":"Z Beizavi","year":"2021","unstructured":"Beizavi Z, Gheibihayat SM, Moghadasian H, Zare H, Yeganeh BS, Askari H, Vakili S, Tajbakhsh A, Savardashtaki A (2021) The regulation of CD47-SIRP\u03b1 signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy? Mol Biol Rep 48:5707\u20135722","journal-title":"Mol Biol Rep"},{"key":"7224_CR4","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/ni.2454","volume":"13","author":"G Le Friec","year":"2012","unstructured":"Le Friec G, Sheppard D, Whiteman P, Karsten CM, Shamoun SA, Laing A, Bugeon L, Dallman MJ, Melchionna T, Chillakuri C, Smith RA, Drouet C, Couzi L, Fremeaux-Bacchi V, K\u00f6hl J, Waddington SN, McDonnell JM, Baker A, Handford PA, Lea SM, Kemper C (2012) The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol 13:2012","journal-title":"Nat Immunol"},{"key":"7224_CR5","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/ana.1135","volume":"50","author":"SS Soldan","year":"2001","unstructured":"Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L, Seya T, McFarland HF, Jacobson S (2001) Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 50:2001","journal-title":"Ann Neurol"},{"key":"7224_CR6","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/eji.201646822","volume":"47","author":"U Ellinghaus","year":"2017","unstructured":"Ellinghaus U, Cortini A, Pinder CL, Le Friec G, Kemper C, Vyse TJ (2017) Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus. Eur J Immunol 47:2017","journal-title":"Eur J Immunol"},{"key":"7224_CR7","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.4049\/jimmunol.1401719","volume":"195","author":"Z Lv","year":"2015","unstructured":"Lv Z, Bian Z, Shi L, Niu S, Ha B, Tremblay A, Li L, Zhang X, Paluszynski J, Liu M, Zen K, Liu Y (2015) Loss of cell surface CD47 clustering formation and binding avidity to SIRP\u03b1 facilitate apoptotic cell clearance by macrophages. J Immunol 195:2015","journal-title":"J Immunol"},{"key":"7224_CR8","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fimmu.2021.629979","volume":"12","author":"TOJ Cockram","year":"2021","unstructured":"Cockram TOJ, Dundee JM, Popescu AS, Brown GC (2021) The phagocytic code regulating phagocytosis of mammalian cells. Front Immunol 12:2021","journal-title":"Front Immunol"},{"key":"7224_CR9","first-page":"2003","volume":"20","author":"YC Hsu","year":"2003","unstructured":"Hsu YC, Acu\u00f1a M, Tahara SM, Peng CA (2003) Reduced phagocytosis of colloidal carriers using soluble CD47. Pharm Res 20:2003","journal-title":"Pharm Res"},{"key":"7224_CR10","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1074\/jbc.M111.263020","volume":"286","author":"E Thorp","year":"2011","unstructured":"Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I (2011) Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cdelta, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem 286:2011","journal-title":"J Biol Chem"},{"key":"7224_CR11","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1136\/gutjnl-2016-313615","volume":"67","author":"E Triantafyllou","year":"2018","unstructured":"Triantafyllou E, Pop OT, Possamai LA, Wilhelm A, Liaskou E, Singanayagam A, Bernsmeier C, Khamri W, Petts G, Dargue R, Davies SP, Tickle J, Yuksel M, Patel VC, Abeles RD, Stamataki Z, Curbishley SM, Ma Y, Wilson ID, Coen M, Woollard KJ, Quaglia A, Wendon J, Thursz MR, Adams DH, Weston CJ, Antoniades CG (2018) MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut 67:2018","journal-title":"Gut"},{"key":"7224_CR12","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.jbspin.2015.01.008","volume":"82","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Ma N, Yang M, Fu H, Liang Y, Huang F, Yang Z, Zhong R (2015) The association of Tyro3\/Axl\/Mer signaling with inflammatory response, disease activity in patients with primary Sj\u00f6gren\u2019s syndrome. Joint Bone Spine 82:2015","journal-title":"Joint Bone Spine"},{"key":"7224_CR13","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1111\/cei.13082","volume":"192","author":"L Xu","year":"2018","unstructured":"Xu L, Hu F, Zhu H, Liu X, Shi L, Li Y, Zhong H, Su Y (2018) Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction. Clin Exp Immunol 192:2018","journal-title":"Clin Exp Immunol"},{"key":"7224_CR14","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1186\/ar4407","volume":"15","author":"G Zizzo","year":"2013","unstructured":"Zizzo G, Guerrieri J, Dittman LM, Merrill JT, Cohen PL (2013) Circulating levels of soluble MER in lupus reflect M2c activation of monocytes\/macrophages, autoantibody specificities and disease activity. Arthritis Res Ther 15:2013","journal-title":"Arthritis Res Ther"},{"key":"7224_CR15","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.2353\/ajpath.2009.080807","volume":"175","author":"JG Weinger","year":"2009","unstructured":"Weinger JG, Omari KM, Marsden K, Raine CS, Shafit-Zagardo B (2009) Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Am J Pathol 175:2009","journal-title":"Am J Pathol"},{"key":"7224_CR16","first-page":"2018","volume":"128","author":"CF Chang","year":"2018","unstructured":"Chang CF, Goods BA, Askenase MH, Hammond MD, Renfroe SC, Steinschneider AF, Landreneau MJ, Ai Y, Beatty HE, da Costa LHA, Mack M, Sheth KN, Greer DM, Huttner A, Coman D, Hyder F, Ghosh S, Rothlin CV, Love JC, Sansing LH (2018) Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage. J Clin Invest 128:2018","journal-title":"J Clin Invest"},{"key":"7224_CR17","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1172\/JCI90520","volume":"127","author":"B Cai","year":"2017","unstructured":"Cai B, Thorp EB, Doran AC, Sansbury BE, Daemen MJ, Dorweiler B, Spite M, Fredman G, Tabas I (2017) MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest 127:2017","journal-title":"J Clin Invest"},{"key":"7224_CR18","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/S0272-5231(21)00669-9","volume":"11","author":"DB Chandler","year":"1990","unstructured":"Chandler DB (1990) Possible mechanisms of bleomycin-induced fibrosis. Clin Chest Med 11:1990","journal-title":"Clin Chest Med"},{"key":"7224_CR19","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.preghy.2018.05.012","volume":"13","author":"S Peng","year":"2018","unstructured":"Peng S, Sun M, Sun X, Wang X, Jin T, Wang H, Han C, Meng T, Li C (2018) Plasma levels of TAM receptors and ligands in severe preeclampsia. Pregnancy Hypertens 13:2018","journal-title":"Pregnancy Hypertens"},{"key":"7224_CR20","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1161\/CIRCULATIONAHA.116.025684","volume":"135","author":"Y Kojima","year":"2017","unstructured":"Kojima Y, Weissman IL, Leeper NJ (2017) The role of efferocytosis in atherosclerosis. Circulation 135:2017","journal-title":"Circulation"},{"issue":"9","key":"7224_CR21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/PCC.0000000000002725","volume":"22","author":"AC Becker","year":"2021","unstructured":"Becker AC, Lantz CW, Forbess JM, Epting CL, Thorp EB (2021) Cardiopulmonary bypass-induced inflammation and myocardial ischemia and reperfusion injury stimulates accumulation of soluble MER. Pediatr Crit Care Med 22(9):822\u2013831","journal-title":"Pediatr Crit Care Med"},{"key":"7224_CR22","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.taap.2012.05.024","volume":"263","author":"YJ Lee","year":"2012","unstructured":"Lee YJ, Lee SH, Youn YS, Choi JY, Song KS, Cho MS, Kang JL (2012) Preventing cleavage of Mer promotes efferocytosis and suppresses acute lung injury in bleomycin treated mice. Toxicol Appl Pharmacol 263:2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"7224_CR23","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1523\/JNEUROSCI.5063-05.2006","volume":"26","author":"SL Shankar","year":"2006","unstructured":"Shankar SL, O\u2019Guin K, Kim M, Varnum B, Lemke G, Brosnan CF, Shafit-Zagardo B (2006) Gas6\/Axl signaling activates the phosphatidylinositol 3-kinase\/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis. J Neurosci 26:2006","journal-title":"J Neurosci"},{"key":"7224_CR24","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1177\/0961203308089990","volume":"17","author":"LE Munoz","year":"2008","unstructured":"Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J (2008) Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 17:2008","journal-title":"Lupus"},{"key":"7224_CR25","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1186\/ar4199","volume":"15","author":"P Recarte-Pelz","year":"2013","unstructured":"Recarte-Pelz P, T\u00e0ssies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC, de Frutos PG (2013) Vitamin K-dependent proteins GAS6 and protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Res Ther 15:2013","journal-title":"Arthritis Res Ther"},{"key":"7224_CR26","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.emc.2019.01.008","volume":"37","author":"RG Wilkerson","year":"2019","unstructured":"Wilkerson RG, Ogunbodede AC (2019) Hypertensive disorders of pregnancy. Emerg Med Clin North Am 37:2019","journal-title":"Emerg Med Clin North Am"},{"key":"7224_CR27","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.placenta.2004.11.007","volume":"27","author":"D Goswami","year":"2006","unstructured":"Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CWG, Sargent IL, von Dadelszen P (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27:2006","journal-title":"Placenta"},{"issue":"8","key":"7224_CR28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/2048872617740833","volume":"8","author":"G Caldentey","year":"2017","unstructured":"Caldentey G, Garcia De Frutos P, Cristobal H, Garabito M, Berruezo A, Bosch X, San Antonio R, Flores-Umanzor E, Perea RJ, De Caralt TM, Rodriguez J, Ortiz-Perez JT (2017) Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 8(8):708\u2013716","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"7224_CR29","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3892\/mmr.2014.1933","volume":"9","author":"C-P Ko","year":"2014","unstructured":"Ko C-P, Yu Y-L, Hsiao P-C, Yang S-F, Yeh C-B (2014) Plasma levels of soluble Axl correlate with severity of community-acquired pneumonia. Mol Med Rep 9:2014","journal-title":"Mol Med Rep"},{"key":"7224_CR30","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1371\/journal.pone.0227187","volume":"15","author":"K Flem-Karlsen","year":"2020","unstructured":"Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Fl\u00f8renes VA, M\u00e6landsmo GM (2020) Soluble AXL as a marker of disease progression and survival in melanoma. PLoS ONE 15:2020","journal-title":"PLoS ONE"},{"key":"7224_CR31","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1097\/MAJ.0000000000000362","volume":"349","author":"Y-W Liu","year":"2015","unstructured":"Liu Y-W, Yang Q-F, Zuo P-Y, Xiao C-L, Chen X-L, Liu C-Y (2015) Elevated serum levels of soluble Axl in acute coronary syndrome. Am J Med Sci 349:2015","journal-title":"Am J Med Sci"},{"key":"7224_CR32","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.ijcard.2014.03.016","volume":"173","author":"M Batlle","year":"2014","unstructured":"Batlle M, Recarte-Pelz P, Roig E, Castel MA, Cardona M, Farrero M, Ortiz JT, Campos B, Pulgarin MJ, Ramirez J, Perez-Villa F, Garcia de Frutos P (2014) AXL receptor tyrosine kinase is increased in patients with heart failure. Int J Cardiol 173:2014","journal-title":"Int J Cardiol"},{"key":"7224_CR33","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3892\/mmr.2017.6393","volume":"15","author":"Y Zhi","year":"2017","unstructured":"Zhi Y, Gao P, Xin X, Li W, Ji L, Zhang L, Zhang X, Zhang J (2017) Clinical significance of sCD163 and its possible role in asthma (review). Mol Med Rep 15:2017","journal-title":"Mol Med Rep"},{"key":"7224_CR34","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.it.2006.03.005","volume":"27","author":"PM Henson","year":"2006","unstructured":"Henson PM, Hume DA (2006) Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 27:2006","journal-title":"Trends Immunol"},{"key":"7224_CR35","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/ars.2012.4834","volume":"18","author":"A Etzerodt","year":"2013","unstructured":"Etzerodt A, Moestrup SK (2013) CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal 18:2013","journal-title":"Antioxid Redox Signal"},{"key":"7224_CR36","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.brainres.2017.11.013","volume":"1679","author":"M Fujimura","year":"2018","unstructured":"Fujimura M, Fujimura T, Kakizaki A, Sato-Maeda M, Niizuma K, Tomata Y, Aiba S, Tominaga T (2018) Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis. Brain Res 1679:2018","journal-title":"Brain Res"},{"key":"7224_CR37","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.5152\/eurjrheum.2016.15088","volume":"3","author":"WASE Hassan","year":"2016","unstructured":"Hassan WASE, Baraka EAE, Elnady BM, Gouda TM, Fouad N (2016) Serum Soluble CD163 and its association with various disease parameters in patients with systemic sclerosis. Eur J Rheumatol 3:2016","journal-title":"Eur J Rheumatol"},{"key":"7224_CR38","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/mds.28424","volume":"36","author":"SK Nissen","year":"2021","unstructured":"Nissen SK, Ferreira SA, Nielsen MC, Schulte C, Shrivastava K, Hennig D, Etzerodt A, Graversen JH, Berg D, Maetzler W, Panhelainen A, M\u00f8ller HJ, Brockmann K, Romero-Ramos M (2021) Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson\u2019s disease. Mov Disord 36:2021","journal-title":"Mov Disord"},{"key":"7224_CR39","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1186\/s13075-016-1214-8","volume":"19","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y (2017) Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Arthritis Res Ther 19:2017","journal-title":"Arthritis Res Ther"},{"key":"7224_CR40","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1007\/s00296-010-1691-z","volume":"32","author":"W Nakayama","year":"2012","unstructured":"Nakayama W, Jinnin M, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Ihn H (2012) Serum levels of soluble CD163 in patients with systemic sclerosis. Rheumatol Int 32:2012","journal-title":"Rheumatol Int"},{"key":"7224_CR41","first-page":"2018","volume":"15","author":"Y Zhi","year":"2018","unstructured":"Zhi Y, Gao P, Li W, Gao F, Zhang J, Lin H, Zhang J (2018) Soluble CD163 levels and CD163+CD14+ monocyte\/macrophage counts in patients with asthma. Iran J Immunol 15:2018","journal-title":"Iran J Immunol"},{"key":"7224_CR42","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1183\/09031936.00080514","volume":"45","author":"HA Periyalil","year":"2015","unstructured":"Periyalil HA, Wood LG, Scott HA, Jensen ME, Gibson PG (2015) Macrophage activation, age and sex effects of immunometabolism in obese asthma. Eur Respir J 45:2015","journal-title":"Eur Respir J"},{"key":"7224_CR43","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1152\/ajprenal.00638.2013","volume":"307","author":"R Gandhi","year":"2014","unstructured":"Gandhi R, Yi J, Ha J, Shi H, Ismail O, Nathoo S, Bonventre JV, Zhang X, Gunaratnam L (2014) Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis. Am J Physiol Renal Physiol 307:2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"7224_CR44","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV (2002) Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:2002","journal-title":"Kidney Int"},{"key":"7224_CR45","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0959-8049(00)00422-6","volume":"37","author":"E Fernebro","year":"2001","unstructured":"Fernebro E, Madsen RR, Fern\u00f6 M, Br\u00fcnner N, Bendahl P, Christensen IJ, Johnson A, Nilbert M (2001) Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients. Eur J Cancer 37:2001","journal-title":"Eur J Cancer"},{"key":"7224_CR46","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.atherosclerosis.2011.01.049","volume":"216","author":"T Sehestedt","year":"2011","unstructured":"Sehestedt T, Lyngb\u00e6k S, Eugen-Olsen J, Jeppesen J, Andersen O, Hansen TW, Linneberg A, J\u00f8rgensen T, Haugaard SB, Olsen MH (2011) Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events. Atherosclerosis 216:2011","journal-title":"Atherosclerosis"},{"key":"7224_CR47","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/rheumatology\/ket156","volume":"52","author":"P Briassouli","year":"2013","unstructured":"Briassouli P, Halushka MK, Reed JH, Molad Y, Fox-Talbot K, Buyon L, Guzman E, Ludomirsky A, Clancy RM, Buyon JP (2013) A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies. Rheumatology (Oxford) 52:2013","journal-title":"Rheumatology (Oxford)"},{"key":"7224_CR48","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.jceh.2018.02.001","volume":"9","author":"\u00d6 Akdo\u011fan","year":"2019","unstructured":"Akdo\u011fan \u00d6, Y\u00fccel AA, Sargin ZG, S\u00f6nmez C, Yilmaz GE, \u00d6zenirler S (2019) Evaluation of plasma urokinase-type plasminogen activator receptor (UPAR) in patients with chronic hepatitis B, C and non-alcoholic fatty liver disease (NAFLD) as serological fibrosis marker. J Clin Exp Hepatol 9:2019","journal-title":"J Clin Exp Hepatol"},{"key":"7224_CR49","first-page":"2003","volume":"10","author":"A Zhou","year":"2003","unstructured":"Zhou A, Huntington JA, Pannu NS, Carrell RW, Read RJ (2003) How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol 10:2003","journal-title":"Nat Struct Biol"},{"key":"7224_CR50","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.4049\/jimmunol.1200625","volume":"190","author":"HB Bae","year":"2013","unstructured":"Bae HB, Tadie JM, Jiang S, Park DW, Bell CP, Thompson LC, Peterson CB, Thannickal VJ, Abraham E, Zmijewski JW (2013) Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages. J Immunol 190:2013","journal-title":"J Immunol"},{"key":"7224_CR51","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.4049\/jimmunol.179.10.7079","volume":"179","author":"Y Tsuruta","year":"2007","unstructured":"Tsuruta Y, Park YJ, Siegal GP, Liu G, Abraham E (2007) Involvement of vitronectin in lipopolysaccaride-induced acute lung injury. J Immunol 179:2007","journal-title":"J Immunol"},{"key":"7224_CR52","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1080\/01902140500324901","volume":"31","author":"B Singh","year":"2005","unstructured":"Singh B, Janardhan KS, Kanthan R (2005) Expression of angiostatin, integrin alphavbeta3, and vitronectin in human lungs in sepsis. Exp Lung Res 31:2005","journal-title":"Exp Lung Res"},{"key":"7224_CR53","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.cca.2015.02.031","volume":"444","author":"H Enocsson","year":"2015","unstructured":"Enocsson H, Sjowall C, Wettero J (2015) Soluble urokinase plasminogen activator receptor\u2013a valuable biomarker in systemic lupus erythematosus? Clin Chim Acta 444:2015","journal-title":"Clin Chim Acta"},{"key":"7224_CR54","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.cellimm.2012.02.001","volume":"274","author":"W Ma","year":"2012","unstructured":"Ma W, Rai V, Hudson BI, Song F, Schmidt AM, Barile GR (2012) RAGE binds C1q and enhances C1q-mediated phagocytosis. Cell Immunol 274:2012","journal-title":"Cell Immunol"},{"key":"7224_CR55","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12017-017-8471-9","volume":"19","author":"S-C Tang","year":"2017","unstructured":"Tang S-C, Yang K-C, Hu C-J, Chiou H-Y, Wu CC, Jeng J-S (2017) Elevated plasma level of soluble form of RAGE in ischemic stroke patients with dementia. NeuroMol Med 19:2017","journal-title":"NeuroMol Med"},{"key":"7224_CR56","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2337\/db12-1528","volume":"62","author":"E Selvin","year":"2013","unstructured":"Selvin E, Halushka MK, Rawlings AM, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC (2013) sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 62:2013","journal-title":"Diabetes"},{"key":"7224_CR57","first-page":"2018","volume":"17","author":"Y Lyu","year":"2018","unstructured":"Lyu Y, Zhao H, Ye Y, Liu L, Zhu S, Xia Y, Zou F, Cai S (2018) Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants. Mol Med Rep 17:2018","journal-title":"Mol Med Rep"},{"key":"7224_CR58","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/2012","volume":"4","author":"L Park","year":"1998","unstructured":"Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1998","journal-title":"Nat Med"},{"key":"7224_CR59","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1161\/01.ATV.21.6.905","volume":"21","author":"T Kislinger","year":"2001","unstructured":"Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann MA, Cataldegirmen G, D\u2019Agati V, Pischetsrieder M, Stern DM, Schmidt AM (2001) Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 21:2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7224_CR60","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3109\/03009742.2013.823517","volume":"43","author":"SR Greisen","year":"2014","unstructured":"Greisen SR, Rasmussen TK, Stengaard-Pedersen K, Hetland ML, Horslev-Petersen K, Hvid M, Deleuran B (2014) Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis. Scand J Rheumatol 43:2014","journal-title":"Scand J Rheumatol"},{"key":"7224_CR61","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen X-F, Wang T, Wang Z, Liao C, Wang Z, Huang R, Wang D, Li X, Wu L, Jia L, Zheng H, Painter M, Atagi Y, Liu C-C, Zhang Y-W, Fryer JD, Xu H, Bu G (2017) Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med 214:2017","journal-title":"J Exp Med"},{"key":"7224_CR62","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/ana.25385","volume":"85","author":"T Ohara","year":"2019","unstructured":"Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T (2019) Serum Soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the Hisayama study. Ann Neurol 85:2019","journal-title":"Ann Neurol"},{"key":"7224_CR63","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/eji.201847801","volume":"49","author":"JWD Blackburn","year":"2019","unstructured":"Blackburn JWD, Lau DHC, Liu EY, Ellins J, Vrieze AM, Pawlak EN, Dikeakos JD, Heit B (2019) Soluble CD93 is an apoptotic cell opsonin recognized by \u03b1x\u03b22. Eur J Immunol 49:2019","journal-title":"Eur J Immunol"},{"key":"7224_CR64","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00384-015-2247-1","volume":"30","author":"RS Olsen","year":"2015","unstructured":"Olsen RS, Lindh M, Vorkapic E, Andersson RE, Zar N, L\u00f6fgren S, Dimberg J, Matussek A, W\u00e5gs\u00e4ter D (2015) CD93 gene polymorphism is associated with disseminated colorectal cancer. Int J Colorectal Dis 30:2015","journal-title":"Int J Colorectal Dis"},{"key":"7224_CR65","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/jcp.25689","volume":"232","author":"GM Tosi","year":"2017","unstructured":"Tosi GM, Caldi E, Parolini B, Toti P, Neri G, Nardi F, Traversi C, Cevenini G, Marigliani D, Nuti E (2017) CD93 as a potential target in neovascular age-related macular degeneration. J Cell Physiol 232:2017","journal-title":"J Cell Physiol"},{"key":"7224_CR66","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.jdiacomp.2014.12.012","volume":"29","author":"TM Shiju","year":"2015","unstructured":"Shiju TM, Mohan V, Balasubramanyam M, Viswanathan P (2015) Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy. J Diabetes Complications 29:2015","journal-title":"J Diabetes Complications"},{"key":"7224_CR67","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1155\/2016\/5678946","volume":"2016","author":"P-M Madrigal-Ru\u00edz","year":"2016","unstructured":"Madrigal-Ru\u00edz P-M, Navarro-Hern\u00e1ndez R-E, Ru\u00edz-Quezada S-L, Corona-Meraz F-I, Mercado V-D, G\u00f3mez-Ba\u00f1uelos E, Castro-Albarran J, Sandoval-Garc\u00eda F, Flores-Alvarado L-J, Mart\u00edn-Marquez B-T (2016) Low CD36 and LOX-1 Levels and CD36 Gene Subexpression Are Associated with Metabolic Dysregulation in Older Individuals with Abdominal Obesity. J Diabetes Res 2016:2016","journal-title":"J Diabetes Res"},{"key":"7224_CR68","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/eci.12192","volume":"44","author":"C Garc\u00eda-Monz\u00f3n","year":"2014","unstructured":"Garc\u00eda-Monz\u00f3n C, Lo Iacono O, Crespo J, Romero-G\u00f3mez M, Garc\u00eda-Samaniego J, Fern\u00e1ndez-Bermejo M, Dom\u00ednguez-D\u00edez A, Rodriguez de Cia J, S\u00e1ez A, Porrero JL (2014) Increased soluble CD 36 is linked to advanced steatosis in nonalcoholic fatty liver disease. Eur J Clin Invest 44:2014","journal-title":"Eur J Clin Invest"},{"key":"7224_CR69","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1177\/1076029616680476","volume":"24","author":"C Ozde","year":"2018","unstructured":"Ozde C, Korkmaz A, Kundi H, Oflar E, Ungan I, Xankisi V, Nurlu N (2018) Relationship between plasma levels of soluble CD40 ligand and the presence and severity of isolated coronary artery ectasia. Clin Appl Thromb Hemost 24:2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"7224_CR70","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/mgg3.1014","volume":"7","author":"R Tapia-Llanos","year":"2019","unstructured":"Tapia-Llanos R, Mu\u00f1oz-Valle JF, Rom\u00e1n-Fern\u00e1ndez IV, Mar\u00edn-Rosales M, Salazar-Camarena DC, Cruz A, Orozco-Barocio G, Guare\u00f1a-Casillas JA, Oregon-Romero E, Palafox-S\u00e1nchez CA (2019) Association of soluble CD40 levels with-1 C> T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus. Mol Genet Genomic Med 7:2019","journal-title":"Mol Genet Genomic Med"},{"key":"7224_CR71","first-page":"2016","volume":"64","author":"P Napole\u00e3o","year":"2016","unstructured":"Napole\u00e3o P, Potapova E, Moleirinho S, Saldanha C, Messias A (2016) Soluble CD40 ligand profiles in patients with septic shock. Clin Hemorheol Microcirc 64:2016","journal-title":"Clin Hemorheol Microcirc"},{"key":"7224_CR72","first-page":"2017","volume":"65","author":"F Sari","year":"2017","unstructured":"Sari F, Gumuslu S, Cetinkaya R, Sarikaya M, Yalcin AD (2017) High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney disease. J Investig Med 65:2017","journal-title":"J Investig Med"},{"key":"7224_CR73","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1158\/0008-5472.CAN-12-1390","volume":"72","author":"KK Wong","year":"2012","unstructured":"Wong KK, Brenneman F, Chesney A, Spaner DE, Gorczynski RM (2012) Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice. Can Res 72:2012","journal-title":"Can Res"},{"key":"7224_CR74","first-page":"2013","volume":"19","author":"A Akman-Karaka\u015f","year":"2013","unstructured":"Akman-Karaka\u015f A, Yalcin AD, Ko\u00e7 S, Gumuslu S, \u015eenol YY, \u00d6zkesici B, Genc GE, Ergun E, Ongut G, Yilmaz E (2013) There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders. Med Sci Monit 19:2013","journal-title":"Med Sci Monit"},{"key":"7224_CR75","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3389\/fimmu.2018.00457","volume":"9","author":"MJ Hossain","year":"2018","unstructured":"Hossain MJ, Morandi E, Tanasescu R, Frakich N, Caldano M, Onion D, Faraj TA, Erridge C, Gran B (2018) The Soluble form of toll-like receptor 2 is elevated in serum of multiple sclerosis patients: a novel potential disease biomarker. Front Immunol 9:2018","journal-title":"Front Immunol"},{"key":"7224_CR76","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s13365-016-0495-7","volume":"23","author":"KM Mothapo","year":"2017","unstructured":"Mothapo KM, Ten Oever J, Koopmans P, Stelma F, Burm S, Bajramovic J, Verbeek M, Rikkert MO, Netea M, Koopman G (2017) Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV\/SIV-related neuropathological conditions. J Neurovirol 23:2017","journal-title":"J Neurovirol"},{"key":"7224_CR77","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/01.RES.0000119804.92239.97","volume":"94","author":"N Kume","year":"2004","unstructured":"Kume N, Kita T (2004) Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture. Circ Res 94:2004","journal-title":"Circ Res"},{"key":"7224_CR78","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3390\/medicina55080493","volume":"55","author":"T Stankova","year":"2019","unstructured":"Stankova T, Delcheva G, Maneva A, Vladeva S (2019) Serum levels of carbamylated LDL and soluble lectin-like oxidized low-density lipoprotein receptor-1 are associated with coronary artery disease in patients with metabolic syndrome. Medicina 55:2019","journal-title":"Medicina"},{"key":"7224_CR79","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3748\/wjg.v21.i26.8096","volume":"21","author":"O Ozturk","year":"2015","unstructured":"Ozturk O, Colak Y, Senates E, Yilmaz Y, Ulasoglu C, Doganay L, Ozkanli S, Oltulu YM, Coskunpinar E, Tuncer I (2015) Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. World J Gastroenterol 21:2015","journal-title":"World J Gastroenterol"},{"key":"7224_CR80","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1161\/JAHA.117.006479","volume":"7","author":"T Skarpengland","year":"2018","unstructured":"Skarpengland T, Skjelland M, Kong XY, Skagen K, Holm S, Otterdal K, Dahl CP, Krohg-S\u00f8rensen K, Sagen EL, Bjerkeli V (2018) Increased levels of lectin-like oxidized low-density lipoprotein receptor-1 in ischemic stroke and transient ischemic attack. J Am Heart Assoc 7:2018","journal-title":"J Am Heart Assoc"},{"key":"7224_CR81","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.jjcc.2010.05.002","volume":"56","author":"N Kume","year":"2010","unstructured":"Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kominami G, Kita T (2010) Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome\u2013comparison with other biomarkers. J Cardiol 56:2010","journal-title":"J Cardiol"},{"key":"7224_CR82","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1111\/j.1365-2567.2012.03559.x","volume":"136","author":"C Weber","year":"2012","unstructured":"Weber C, M\u00fcller C, Podszuweit A, Montino C, Vollmer J, Forsbach A (2012) Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 136:2012","journal-title":"Immunology"},{"key":"7224_CR83","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/infdis\/jiv145","volume":"212","author":"E Krastinova","year":"2015","unstructured":"Krastinova E, Lecuroux C, Leroy C, Seng R, Cabie A, Rami A, Venet A, Meyer L, Goujard C (2015) High soluble CD14 levels at primary HIV-1 infection predict more rapid disease progression. J Infect Dis 212:2015","journal-title":"J Infect Dis"},{"key":"7224_CR84","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1089\/jir.2014.0155","volume":"35","author":"E Medhat","year":"2015","unstructured":"Medhat E, Salama H, Fouad H, Abd El Haleem H, Said M, El-Nahaas SM, Omran D (2015) Serum soluble CD14 in Egyptian patients with chronic hepatitis C: its relationship to disease progression and response to treatment. J Interferon Cytokine Res 35:2015","journal-title":"J Interferon Cytokine Res"},{"key":"7224_CR85","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1189\/jlb.3HI0117-005RR","volume":"102","author":"D Zhao","year":"2017","unstructured":"Zhao D, Guo M, Liu B, Lin Q, Xie T, Zhang Q, Jia X, Shu Q, Liang X, Gao L, Ma C (2017) Frontline science: tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE. J Leukoc Biol 102:2017","journal-title":"J Leukoc Biol"},{"key":"7224_CR86","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4049\/jimmunol.176.3.1411","volume":"176","author":"H Geng","year":"2006","unstructured":"Geng H, Zhang GM, Li D, Zhang H, Yuan Y, Zhu HG, Xiao H, Han LF, Feng ZH (2006) Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J Immunol 176:2006","journal-title":"J Immunol"},{"key":"7224_CR87","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1074\/jbc.M113.488478","volume":"288","author":"K M\u00f6ller-Hackbarth","year":"2013","unstructured":"M\u00f6ller-Hackbarth K, Dewitz C, Schweigert O, Trad A, Garbers C, Rose-John S, Scheller J (2013) A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3). J Biol Chem 288:2013","journal-title":"J Biol Chem"},{"key":"7224_CR88","first-page":"2018","volume":"10","author":"F Li","year":"2018","unstructured":"Li F, Li N, Sang J, Fan X, Deng H, Zhang X, Han Q, Lv Y, Liu Z (2018) Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection. Cancer Manag Res 10:2018","journal-title":"Cancer Manag Res"},{"key":"7224_CR89","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1128\/JVI.00006-15","volume":"89","author":"KL Clayton","year":"2015","unstructured":"Clayton KL, Douglas-Vail MB, Nur-ur Rahman AK, Medcalf KE, Xie IY, Chew GM, Tandon R, Lanteri MC, Norris PJ, Deeks SG, Ndhlovu LC, Ostrowski MA (2015) Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression. J Virol 89:2015","journal-title":"J Virol"},{"key":"7224_CR90","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fimmu.2020.02020","volume":"11","author":"W Liu","year":"2020","unstructured":"Liu W, Xu L, Liang X, Liu X, Zhao Y, Ma C, Gao L (2020) Tim-4 in health and disease: friend or foe? Front Immunol 11:2020","journal-title":"Front Immunol"},{"key":"7224_CR91","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1:2004","journal-title":"NeuroRx"},{"key":"7224_CR92","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/rheumatology\/keq459","volume":"50","author":"C Ekman","year":"2011","unstructured":"Ekman C, J\u00f6nsen A, Sturfelt G, Bengtsson AA, Dahlb\u00e4ck B (2011) Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology 50:2011","journal-title":"Rheumatology"},{"key":"7224_CR93","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1155\/2020\/1496935","volume":"2020","author":"H Liu","year":"2020","unstructured":"Liu H, Wang S, Zhang Z, Jie J, Song L, Hua S, Battaglia S (2020) Diagnostic value of soluble form of mer tyrosine kinase (sMerTK) in tuberculous pleural effusion and malignant pleural effusion. Biomed Res Int 2020:2020","journal-title":"Biomed Res Int"},{"key":"7224_CR94","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.cca.2010.09.009","volume":"411","author":"M Chmielewski","year":"2010","unstructured":"Chmielewski M, Bragfors-Helin AC, Stenvinkel P, Lindholm B, Anderstam B (2010) Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients. Clin Chim Acta 411:2010","journal-title":"Clin Chim Acta"},{"key":"7224_CR95","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1186\/ar3853","volume":"14","author":"Y Li","year":"2012","unstructured":"Li Y, Zhao LD, Tong LS, Qian SN, Ren Y, Zhang L, Ding X, Chen Y, Wang YX, Zhang W, Zeng XF, Zhang FC, Tang FL, Zhang X, Ba DN, He W, Cao XT, Lipsky PE (2012) Aberrant CD200\/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity. Arthritis Res Ther 14:2012","journal-title":"Arthritis Res Ther"},{"key":"7224_CR96","first-page":"2015","volume":"37","author":"WA Hassan","year":"2015","unstructured":"Hassan WA, Baraka EA, Fouad NA (2015) Clinical significance of soluble programmed death-1(sPD-1) in rheumatoid arthritis patients: Relation to disease activity and functional status. Egypt Rheumatol 37:2015","journal-title":"Egypt Rheumatol"},{"key":"7224_CR97","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1159\/000006876","volume":"91","author":"VL Serebruany","year":"1999","unstructured":"Serebruany VL, Murugesan SR, Pothula A, Semaan H, Gurbel PA (1999) Soluble PECAM-1, but Not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain. Cardiology 91:1999","journal-title":"Cardiology"},{"key":"7224_CR98","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/S0165-5728(99)00092-2","volume":"99","author":"J Losy","year":"1999","unstructured":"Losy J, Niezgoda A, Wender M (1999) Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J Neuroimmunol 99:1999","journal-title":"J Neuroimmunol"},{"key":"7224_CR99","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1034\/j.1600-0404.2002.01339.x","volume":"106","author":"J Zaremba","year":"2002","unstructured":"Zaremba J, Losy J (2002) sPECAM-1 in serum and CSF of acute ischaemic stroke patients. Acta Neurol Scand 106:2002","journal-title":"Acta Neurol Scand"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07224-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07224-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T23:56:16Z","timestamp":1700438176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07224-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7224"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07224-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}